Articles liés à Efficiency of Glaxo Smithkline’s Distribution...

Efficiency of Glaxo Smithkline’s Distribution Channel in Bangladesh: Industrial Analysis, Swot Analysis, 4P’S Of Gsk, Push and Pull Stratagies - Couverture souple

Shovin, Md. Asaduzzaman

 
9783846532454: Efficiency of Glaxo Smithkline’s Distribution Channel in Bangladesh: Industrial Analysis, Swot Analysis, 4P’S Of Gsk, Push and Pull Stratagies
Couverture souple
ISBN 10 : 3846532452 ISBN 13 : 9783846532454
Editeur : LAP LAMBERT Academic Publishing, 2011

Synopsis

‘GSK’ is one of the leading corporate houses and Multi-Nationals in Bangladesh with the policy to ensure consumer’s satisfaction by producing safe and intrinsic quality products with authentic taste through adoption of modern processing technology and procuring raw materials from selected sources. Pharmaceutical companies around the globe are continuously searching for extreme quality and innovation since their only product drug is highly sophisticated and directly related to the alleviation of human sufferings. In herring this responsibility on shoulder GlaxoSmithKline is operating globally as a world-class research based pharmaceutical company with its excellent development capabilities, regulatory expertise, global marketing reach, and financial strengths. The augmentation of GSK’s pipeline through in-licensing, co-marketing and co-promotion agreements ensures balance in its portfolio, and provides the basis for sustainable growth in a high-risk business like drug development. GSK has an extensive history of successful collaborations, and it brings a "can do attitude", rapid response times, and a relentless focus on achieving mutual goals.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Présentation de l'éditeur

‘GSK’ is one of the leading corporate houses and Multi-Nationals in Bangladesh with the policy to ensure consumer’s satisfaction by producing safe and intrinsic quality products with authentic taste through adoption of modern processing technology and procuring raw materials from selected sources. Pharmaceutical companies around the globe are continuously searching for extreme quality and innovation since their only product drug is highly sophisticated and directly related to the alleviation of human sufferings. In herring this responsibility on shoulder GlaxoSmithKline is operating globally as a world-class research based pharmaceutical company with its excellent development capabilities, regulatory expertise, global marketing reach, and financial strengths. The augmentation of GSK’s pipeline through in-licensing, co-marketing and co-promotion agreements ensures balance in its portfolio, and provides the basis for sustainable growth in a high-risk business like drug development. GSK has an extensive history of successful collaborations, and it brings a "can do attitude", rapid response times, and a relentless focus on achieving mutual goals.

Biographie de l'auteur

Md. Asaduzzaman Shovin has completed his MBA and BBA from Department of Business Administration of American International University Bangladesh. He works in different type project and organization in the field of Finance. Now he is an Article student of ICAB under Deloitte Touch Tohmatsu.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Éditeur
LAP LAMBERT Academic Publishing
Date d'édition
2011
Langue
anglais
ISBN 10 
3846532452
ISBN 13 
9783846532454
Reliure
Broché
Nombre de pages
72
Coordonnées du fabricant
non disponible
Personne responsable
KreGa Onlinehandel GmbH
4950000000000
info@krega-onlinehandel.de

Birkenweg 31
Brakel
33034
Allemagne